Found 34 matching trials
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer PHASE1 A first in human study to evaluate the safety and preliminary antitumor act...
Show More Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Learn More & Join Trial
Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma PHASE1 The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Show More Location
The second affiliated hospital of Zhejiang University
Learn More & Join Trial
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) PHASE3 The main aim of this study is to compare the efficacy of short-course versu...
Show More Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
Learn More & Join Trial
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab PHASE1 This is an open-label, phase 1/2, multiple-indication platform study to exp...
Show More Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
Learn More & Join Trial
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC PHASE3 The goal of this multicenter randomized controlled phase III trial is to co...
Show More Learn More & Join Trial
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors PHASE1 The purpose of this platform study is to evaluate the safety, tolerability,...
Show More Location
Ironwood Cancer and Research Centers
Learn More & Join Trial
Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma. PHASE2 Pancreatic ductal adenocarcinoma (PDAC) exhibits significant heterogeneity,...
Show More Learn More & Join Trial
Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX PHASE2 Induction mFOLFIRINOX has become the standard in the management of locally ...
Show More Learn More & Join Trial